FDA Approved: VYLEESI — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved VYLEESI (bremelanotide) under an original NDA for the treatment of hypoactive sexual desire disorder in premenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Vyleesi (Bremelanotide)

Snippet

ORIG AP for VYLEESI (BREMELANOTIDE)